Pedro Beltran
President and CEO at BridgeBio Oncology Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 months
- Director since
- 2026
4 months of board service in total across 1 board, counting each seat separately. Longest: BridgeBio Oncology Therapeutics Inc., 4 months.
BridgeBio Oncology Therapeutics Inc.
Director · President and CEO
Chief executive roles
BridgeBio Oncology Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | BridgeBio Oncology Therapeutics Inc. | Shares withheld for tax | −1,047 | $7.80 | $8,167 |
| Apr 1, 2026 | BridgeBio Oncology Therapeutics Inc. | Shares withheld for tax | −1,047 | $9.03 | $9,454 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.